Copyright © 2012. Plural Publishing, Inc. All rights reserved.

May not be reproduced in any form without permission from the publisher, except fair uses permitted under U.S. or

Index

A site of lesion, 242

symptoms, 240–241
ABR (auditory brainstem response) AIED (autoimmune inner ear disease),
and BM basilar membrane, 29 204–209
TW (traveling wave) in cochlea, 29 Alport syndrome, 378
wave I, 37 Alzheimer’s disease (AD), 297–303
Acoustic neuroma, 376, 382 American Academy of Otolaryngology —
additional information, 250 Head and Neck Surgery
audiologic examination Committee on Hearing and Equilibrium,
acoustic reflexes, 244 195
auditory brainstem response, 244–246 Amikacin, 188
otoacoustic emissions, 243–244 Aminoglycosides, 188–189, 191
pure-tone threshold, 243 Amoxicillin, 117
pure-tone threshold/speech recognition AN/AD (auditory neuropathy/auditory
tests, 243 dyssynchrony), 382–383
speech recognition test, 243 audiologic examination, 261–262
vestibular evaluation, 246 case study
case studies audiologic examination result, 264–267
additional information, 252, 254 audiologic recommendation/result, 267
audiologic examination result, 250–252, history, 264
254–255 impression, 267
audiologic/medical management, 254 medical examination result, 267
audiologic recommendation, 253 etiology, 261
history, 250, 253 medical/audiologic management, 263–264
impression, 250, 254 medical examination, 262–263
medical examination result, 250, 253– overview, 259–260
254, 257 pathology, 261
medical recommendation/management, prevalence, 260–261
253 site of lesion, 261
applicable copyright law.

etiology, 242 symptoms, 260

medical examination, 246–247 Analgesics, 187–189
medical management, 248–249 Anatomy. See structure under body systems
overview, 239–240 main headings
pathology, 241 Aneurysms, 286, 287
prevalence, 241 Ankylosis, 378

EBSCO Publishing : eBook Academic Collection (EBSCOhost) - printed on 2/3/2018 6:22 AM via AUB UNIV LIBRARIES
AN: 746799 ; Musiek, Frank E..; Disorders of the Auditory System
Account: s6501866
 408 Disorders of the Auditory System
Copyright © 2012. Plural Publishing, Inc. All rights reserved. May not be reproduced in any form without permission from the publisher, except fair uses permitted under U.S. or

Antiarrhythmics, 354 Time Compressed Speech, 71

Antibiotics, 117, 187 classification for hearing loss degree, 65
Anticoagulants, 286, 287 electroacoustic measures
Anticonvulsants, 325, 354 and ABR testing with eighth nerve
Antidepressants, 354 involvement, 75
Antiemetics, 173, 199 DPOAEs (distortion product otoacoustic
Antimalarials, 187, 189 emissions), 72–74
Antimicrobial drugs, 117 limitations, 75
Antineoplastics, 187, 188 OAEs (otoacoustic emissions): diagnostic
Antioxidants, 191 limitations, 75
Antiplatelet agents, 286, 287 OAEs (otoacoustic emissions): overview,
Anxiety, 353 72
Anxiolytics, 354 and pure-tone audiometry abnormalities,
Apert syndrome, 376, 377 75
Aport syndrome, 375 TEOAEs (transient evoked otoacoustic
Aricept, 299 emissions), 72–74
Arryhythmias, 132 electrophysiologic measures
Arterial alteration, acquired, 350 ABR (auditory brainstem response),
Arteriovenous shunts, 347 76–79
Aspirin, 287 ABR/MRI, retrocochlear lesions, 78–79
Astrocytomas, 376 evoked potentials (EP), 75
Ataxia, 375 LAER (late average evoked response
Atherosclerosis, 285–286 potentials), 80–82
Atresia. See Aural atresia MLR (middle latency response), 79–80,
Atrial fibrillation, 287 82
Audiologic assessment, 71. See also Vestibular hearing sensitivity examination, 63–66
assessment Jerger classification system, 65, 67
acoustic reflex testing SAT (speech awareness threshold), 65–66
acoustic reflex decay measurement, 69 speech audiometry, 65–66
acoustic stapedial reflex measure, 68–69 SRT (speech recognition threshold), 65–66
described, 68 typanometry
audiometers, 63 classification systems, 66–68
auditory processing tests described, 66
behavioral assessment, 69 universal descriptors, 67–68
binaural function, 69 Auditory hallucinations, 360–364
Dichotic Digits, 71 Auditory system
dichotic listening, 69 central auditory system
Dichotic Sentences, 71 auditory cortex/subcortex: function,
Duration Pattern Test, 71 47–48
Filtered Words, 71 auditory cortex/subcortex: structure,
Frequency Pattern Test, 71 45–47
Gaps-In-Noise, 71 CC (corpus callosum): function, 48–49
Listening in Spatialized Noise (LISN-S), CC (corpus callosum): structure, 48
71 cerebrum (coronal view), 45–47
applicable copyright law.

Masking Level Difference (MLD), 71–72 CN (cochlear nucleus): function, 41

monaural low-redundancy speech CN (cochlear nucleus): structure, 39–41
perception, 69 efferent system: stucture/function, 50
Random Gap Detection, 71 IC (inferior colliculus: function, 44
speech perception, 69 IC (inferior colliculus: structure, 43–44
Staggered spondaic words, 71 LL (lateral lemniscus): function, 43
temporal processing, 69, 71 LL (lateral lemniscus): structure, 42–43

EBSCO Publishing : eBook Academic Collection (EBSCOhost) - printed on 2/3/2018 6:22 AM via AUB UNIV LIBRARIES
AN: 746799 ; Musiek, Frank E..; Disorders of the Auditory System
Account: s6501866
 409
Index
Copyright © 2012. Plural Publishing, Inc. All rights reserved. May not be reproduced in any form without permission from the publisher, except fair uses permitted under U.S. or
MGB (medal geniculated body):
function, 44–45
MGB (medal geniculated body):
structure, 44
SOC (superior olivary complex):
function, 42
SOC (superior olivary complex):
structure, 41–42
vascular supply, 51–52
efferent system: structure, 47–48, 50
overview, 11–12
peripheral
AN (auditory nerve): function
action potential, 37
adaptation, 38–39
frequency coding, 38
intensity coding/neuron (SFR)
spontaneous firing rate, 38
PSTH (post-stimulus time histogram)
tone burst pattern, 37
temporal coding, 38
AN (auditory nerve): structure,
path to and in brain from cochlea,
35–36
tonotopic organization, 37
Types I and II, 35
BM (basilar membrane): function, 28
BM (basilar membrane): structure, 22–24,
28–29
BM basilar membrane and TW (traveling
wave): function, 29–30
CA (cochlear channel): function, 22
CA (cochlear channel): structure, 22, 24
CM (cochlear microphonic), 34
cochlea, bony: function, 21
cochlea, bony: structure, 20–21
cochlea, membranous: function, 29–35
cochlea, membranous: structure, 21–29
cochlear compression/rarefaction waves,
29
cochlear duct lateral wall: structure, 25
cochlear electrophysiology, 33
cochlear mechanics: function, 29–33
ductus reuniens: function, 22
applicable copyright law.
EAM (external auditory meatus):
function, 15–16
EAM (external auditory meatus):
structure, 14
endocochlear potential, 33–34
endolymph: structure, 22–23
Eustachian tube: function, 18
EBSCO Publishing : eBook Academic Collection (EBSCOhost) - printed on 2/3/2018 6:22 AM via AUB UNIV LIBRARIES
AN: 746799 ; Musiek, Frank E..; Disorders of the Auditory System
Account: s6501866
frequency in cochlea, 29–30
hair cell mechanics: function, 30–33
hair cell response summation to sound
stimulus along BM, 34
helicotrema: function, 22
Hensen’s stripe: structure/function, 25
IAM (internal auditory meatus:
structure, 13
IHC (inner hair cells): function, 27–28
IHC (inner hair cells): structure, 24–25
IHCs (inner hair cells): structure, 26
IHCs (inner hair cells) and stereocilia:
function, 31
IHCs (inner hair cells) and transduction
process: function, 33
IHCs (inner hair cells) fluid flow:
function, 31
membrane): structure, 28–29
middle ear: function, 17–20
middle ear: structure, 16–17
OHCs (outer hair cells): function, 26–28
OHCs (outer hair cells): structure, 26–27
OHCs (outer hair cells) and BM (basilar
membrane)/stereocilia deflection,
31–32
OHCs (outer hair cells) and transduction
process: function, 31–33
OHCs’ (outer hair cells’) stereocilia:
structure, 31
organ of Corti: structure, 24
OSL (osseous spiral lamina): structure, 21
ossicular chain: function, 17–18
outer ear: function, 14–16
outer ear: structure, 13–14
perilymph: structure, 22–23
pinna: function, 14–15
pinna: structure, 13–14
Reissner’s membrane: structure, 22–23
reticular lamina: structure, 25
round window: structure, 22
scalae (membranous cochlear ducts):
structure, 22
sensory cells, 26–28. See also IHC (inner
hair cells) in this section; OHC (outer
hair cells) in this section
spiral ligament: structure, 25–26
SP (summating potential), 34–35
stapes footplate/oval window/
vestibule/scala vestibuli: function,
22
stereocilia: structure/function, 25–28
 410 Disorders of the Auditory System
Copyright © 2012. Plural Publishing, Inc. All rights reserved. May not be reproduced in any form without permission from the publisher, except fair uses permitted under U.S. or
Auditory system; peripheral  (continued)
stria vascularis: function, 25–26
supporting cells: structure/function,
28–29
temporal bone: structure, 12–13
TM (tympanic membrane): function, 17–18
TM (tympanic membrane): structure,
16–17
transformer action: function, 18
vascular supply, 51
VA (vestibular channel): function, 22, 24
vascular supply
central auditory system, 51–52
peripheral system, 51
vestibular system, 58–59
vestibular system
defined, 52
vascular supply, 58–59
vestibular system: function
VCR (vestibulocolic) reflex, 56
VOR (vestibulo-ocular) reflex, 56–58
VSR (vestibulospinal) reflex, 56
vestibular system: structure
connections allowing electrical signals to
be interpreted as motion, 56
connections enabling compensation of
the vestibuo-ocular reflex, 55–56
connections responsible for secondary
pallor, sweating, nausea, vomiting
reactions from lost function, 56
and Ménière’s disease, 52
peripheral aspect, 52–55
physical connection to peripheral
auditory system, 52
routing of vestibular end organ electrical
activity through eighth cranial
nerve, 52–55
second-order neurons, 55
semicircular canals, 52–54
Aural atresia, 106–109
Aural fullness, 194, 199
Azathioprine, 299
B
applicable copyright law.
Barotrauma, 221
Von Békésy, Georg (1899–1972)
place theory, 29
Benzodiazepines, 173
Biotinidase deficiency, 375, 380
Blindness, 381
EBSCO Publishing : eBook Academic Collection (EBSCOhost) - printed on 2/3/2018 6:22 AM via AUB UNIV LIBRARIES
AN: 746799 ; Musiek, Frank E..; Disorders of the Auditory System
Account: s6501866
Brachiocephly, 378
Brain plasticity, 281
Branchial fistulas, 376
Branchiootorenal syndrome, 376, 378
C
CANS (central auditory nervous system)
disorders. See also Degenerative
disorders of CANS; Learning
problems associated with CANS;
Mass lesions; Mass lesions of CANS;
Neurotoxicity and CANS; Surgery
altering CANS function; TBI
(traumatic brain injury) and CANS;
Temporal lobe epilepsy and CANS;
Vascular disorders of CANS
anatomic factor overview, 280
anatomy, 279
audiology overview, 280
brain plasticity, 281
overview, 279
test types, 280–281
CAPD (central auditory processing disorder).
See Learning problems associated
with CANS
Cataracts, 375
juvenile, 376
CBT (cognitive behavioral therapy), 353–354
Central auditory disorders, 383
Cephalosporins, 117
Cerebral vasculitis, 287
Cerebral vasospasms/arterial occlusion, 287
CHAMP (cochlear hydrops masking
procedure), 197
Charcot-Marie-Tooth disease, 382–383
CHARGE (coloboma of the eye, heart defects,
atresia of the choanae, retardation
of growth/development, genital
anomalies, ear abnormalities or
deafness) syndrome, 107, 376,
381–382
Chemotherapy, 206
Cholesteatoma, 123–131
Cisplatinum, 188–189, 191
Classification of hearing loss
nonsyndromic hearing loss (NSHL),
370–374
onset of loss
postlingual, 370
prelingual, 370–371
 411
Index
Copyright © 2012. Plural Publishing, Inc. All rights reserved. May not be reproduced in any form without permission from the publisher, except fair uses permitted under U.S. or

syndromic hereditary hearing loss, E

374–376
types of loss. See under Hearing loss main Electrocochleography, 21
entry AP of, 37
Cleft, 115 and CM, 34
Cleft palate, 376 far-field recordings, 34
CNS abnormalities, 380 transtympanic, 34
Cochlear aqueduct enlarged, 377 Encephalitis, 324
Cochlear hydrops Endolymphatic hydrops. See Ménière disease
and SP (summating potential), 34 Ependymomas, 376, 382
Cochlear implants, 173 Epley maneuver, 173
Cogan’s syndrome, 205 Erythromycin, 188
Cognitive compromise, 380–381 Escherichia coli, 124
Colitis, ulcerative, 205 Eustachian tube dysfunction, 109–114
Compulsive disorder, 361–362 Exelon, 299
Craniofacia dysotosis, 378 Exotoses, 152–153
Cupulolithiasis, traumatic, 173 External ears deformed, 379
Cyclophosphamide, 206, 299
Cyclosporine, 299 F
Cysts or clefts, 376 Facial bone abnormalities, 379
Famvir, 226
D Flattened facial appearance, 379
5-fluorouracil, 188
Davis, Hallowell (1896–1992), 33 Focal pontine ischemia, 221
Degenerative disorders of CANS. See also Fosfomycin, 191
Alzheimer’s disease (AD); MS Fusion of skull bones, fingers, toes,
(multiple sclerosis) prematurely, 376
audiologic examination, 299–303 Fusion of skull bones prematurely, 376
etiology, 298
medical diagnosis, 298–299
medical management, 299 G
overview, 297 Genetics
prevalence, 297–298 autosomal dominant inheritance pattern,
site of lesion, 298 363–364, 366–367
symptoms, 297 autosomal recessive inheritance pattern,
Depression, 353, 361 363, 365
Developmental motor delays, 381 hearing loss evaluation/counseling
Dexamathasone, 206, 209 counseling, 388–389
Diabetes, 115 evaluation, 386–388
Diabetes mellitus, 229–230 overview, 385–386
Diaphoresis, 132 mitochondrial inheritance, 367–368, 369
Dichotic word listening test (DWLT), 287 multifactorial inheritance patterns, 368–370
Diet, low-salt, 199–200, 202 overview/primer, 361–363, 389
Disequilibrium, 241. See also Vertigo pedigree symbols, 364
applicable copyright law.

Diuretics, 187, 199 resources, 361

Diuretics, loop, 188–189 X-linked inheritance pattern, 367–369
Dopamine cholinesterase inhibitors, 363 Gentamicin, 188, 199–200, 202
Down syndrome, 298 GIN (Gaps-in-Noise) test, 289, 311
DSI (Dichotic Sentence Identification), 302 Gliomas, 382
Dysphagia, 132 Glitaramer acetate, 299
Dystopia canthorum, 376–378 Glomerulo nephritis, progressive, 375

EBSCO Publishing : eBook Academic Collection (EBSCOhost) - printed on 2/3/2018 6:22 AM via AUB UNIV LIBRARIES
AN: 746799 ; Musiek, Frank E..; Disorders of the Auditory System
Account: s6501866
 412 Disorders of the Auditory System
Copyright © 2012. Plural Publishing, Inc. All rights reserved. May not be reproduced in any form without permission from the publisher, except fair uses permitted under U.S. or

Glomus tumors, 130–138 Interferon-beta, 299

Glutamate receptor antagonists, 354 Intracerebral hemorrhage, 286
Goiter, 375 Itard, Jean Marc Gaspard (1774–1838), 354
Goldenhar syndrome, 107
Guild, Stacy, 130 J
Jannetta, Peter, 268
H Jervell and Lange-Nielsen syndrome, 375, 379
Haemophilus influenzae, 115
Hallucinations. See Auditory hallucinations K
Hallucinatory illicit drugs, 363
Kanamycin, 188
Headache, 132
Kemp, David, 72
Hearing aids
bone-anchored, 109, 222
CROS (contralateral routing of signal), 173, L
222 Labyrinthine membrane rupture, 221
for Ménière’s disease, 200 Landau-Kleffner syndrome, 323–324
as tinnitus maskers, 355 Learning problems associated with CANS,
Hearing loss 332–334
central auditory dysfunction Lidocaine, 354
defined, 370 Lupus, 221
conductive, 106, 140–141, 147, 150, 375–376,
379–380
defined, 65, 370
M
mixed, 139, 141, 376, 379–380 Macrolides, 117
defined, 65, 370 Malformations, congenital
noise-induced, 178–187 auditory nerve/IAM (internal auditory
sensorineural, 132, 139, 147–148, 173, 194, meatus), 385
200, 206, 209, 211, 226, 240, 347, external/middle ear
375–381. See also SSHL (sudden Bing-Siebenmann malformation, 385
idiopathic sensorineural hearing Mondini aplasia, 384
loss) main entry Scheibe malformations, 384–385
defined, 65, 370 inner ear
sudden, 240 aplasias, 384–385
Heart disease, congenital, 380 vestibular/cochlear aqueduct
Heavy metals. See Neurotoxicity and CANS malformations, 385
Heparin, 287 Mandibulofacial dysotosis, 376
Herpes viruses, 221 Mass lesions of CANS
Heterochromia irises, 376 audiologic examination, 284
HINT (hearing in noise test), 311 auditory brainstem response, 290
HIV, 115 behavioral test procedures, 287–290
Hyperacusis, 357–360 dichotic listening tests, 287–288
Hypertension, 132, 134 eletrophysiologic tests, 290–292
Hypotonia, 380 late responses (N1, P2), 291
applicable copyright law.

middle latency response, 290–291

monaural low redundancy speech tests,
I 289
Immittance audiometry. See acoustic reflex P300 response, 291–292
testing under Audiologic assessment temporal processing tests, 288–289
main entry; typanometry under medical diagnosis, 283
Audiologic assessment main entry medical management, 283–284

EBSCO Publishing : eBook Academic Collection (EBSCOhost) - printed on 2/3/2018 6:22 AM via AUB UNIV LIBRARIES
AN: 746799 ; Musiek, Frank E..; Disorders of the Auditory System
Account: s6501866
 413
Index
Copyright © 2012. Plural Publishing, Inc. All rights reserved. May not be reproduced in any form without permission from the publisher, except fair uses permitted under U.S. or

overview, 281 MS (multiple sclerosis)  (continued)

pathology, 282–283 late potentials (N1, P2, P300), 301
prevalence, 282 medical diagnosis, 298–299
site of lesions, 283 medical management, 299
symptoms, 281–282 middle latency response, 301
Mastoiditis, 128 monaural low redundancy speech tests, 300
Ménière, Prosper (1799–1862), 194 overview, 297
Ménière’s disease, 140, 205–206, 211, 222, prevalence, 297–298
230–231, 351 site of lesion, 298
audiologic examination, 197–199 symptoms, 297
as auditory and vestibular pathology, 52 temporal processing tests, 300
case study: bilateral Multiple sclerosis, 221
audiologic examination result, 200–201 case study, 303–305
audiologic recommendation/ Mumps, 221
management, 200
history, 200
impression, 200
N
information, 200 Nearsightednedness, severe, 379
medical examination result, 200 Neomycin, 188
case study: unilateral Nephritis, progressive, 378
audiologic examination result, 202–204 Neurofibromatosis type II, 240, 242, 376
audiologic recommendation/ Neurofibromatosis types I and II, 382
management, 202 Neuromonics Oasis tinnitus treatment, 356–
history, 202 357, 360
impression, 202 Neurotoxicity and CANS
medical examination result, 202 heavy metals, solvents, and styrene, 307–
medical recommendations/ 309, 311–312
management, 202 hyperbilirubinemia (HB), 309–313
etiology, 196 mercury poisoning, 312–315
incidence/prevalence, 196 Noise-induced hearing loss, 178–187
medical examination, 199–200 Norrie disease, 380–381
neuroaudiologic evaluation, 75
overvew, 194–195
pathology, 196
O
site of lesion, 196–197 OAEs (otoacoustic emissions)
Meningiomas, 376, 382 mechanism of emission creation, 32
Meningitis, 128, 324 Occlusive disease, 286
Mental retardation, 375 OSHA (Occupational Safety and Health
Metotrexate, 206, 299 Administration) of Department of
Microtia, 106 Labor noise exposure standards, 173
Middle/inner ear malformations, 376 Ossicuar chain dislocation, 154
Migraine, 221 Osteomas, 153
Mondini dyspasia, 375 Otitis, external, 152
Moraxella catarrhalis, 115 Otitis media, 114–121
applicable copyright law.

MS (multiple sclerosis), 297 Otosclerosis, 138–142

auditory brainstem response, 301 Ototoxicity, 187–194
behavioral test procedures, 300–301
binaural interaction tests, 300–301
dichotic listening tests, 300
P
electrophysiologic tests, 301 Palpitations, 132
etiology, 298 Paragangliomas, 347

EBSCO Publishing : eBook Academic Collection (EBSCOhost) - printed on 2/3/2018 6:22 AM via AUB UNIV LIBRARIES
AN: 746799 ; Musiek, Frank E..; Disorders of the Auditory System
Account: s6501866
 414 Disorders of the Auditory System
Copyright © 2012. Plural Publishing, Inc. All rights reserved. May not be reproduced in any form without permission from the publisher, except fair uses permitted under U.S. or

Pendred syndrome (PDS), 374–375 Staphylococcus aureus, 124

Penicillamine, 309 Steroids, systemic, 206
Perilymph fistulas, 206, 211, 221, 222, 230–231 Stickler syndrome, 376, 379
Physiology. See function under body systems Strepococcus pneumoniae, 115
main headings Streptococcus epidermidis, 124
Pierre Robin syndrome, 107 Streptomycin, 188
Plavix, 287 Strokes, 347
Prednisone, 200, 202, 209, 226 Styrene. See Neurotoxicity and CANS
Pregnancy, 138 Succimer, 309
Presbycusis, 209–213 Surgery. See also Surgery altering CANS
Progressive muscular relaxation, 353 function
Pseudomonas aeruginosa, 124 adenoidectomy, 117
angioplasty, 287
atretic ear/canal, 109
Q canal resurfacing, 215
Quinine, 187, 191 carotid endarterectomy, 287
commissurotomy, 325–326
cranitomy
R with mastoidectomy, 147–148
Razadyne, 299 dehiscence grafting, 216, 218
Refsum disease, 375 hematoma decompression/evacuation, 287
Retinal flekes, 375 labyrnthectomy, transmastoid
Retinal hyperplasia/necrosis, 375 (nonfunctional hearing vertigo
Retinitis pigmentosa, 375, 377, 380 control), 200
Rheumatoid arthritis, 205 mastoidectomy, 127, 130, 135–136
Rinne test, 172 with cranitomy, 147–148
Rubella, 221 CWD (canal wall down), 127
CWU (canal wall up), 127
for otosclerosis, 140
S stapedectomy, 141
Salicylates, 189, 191 temporal lobectomies, 325–326
Schizophrenia, 361, 363 temporal lobectomies, anterior, 328–329
Scholesteatoma audiologic examination, 125 third window closure, 215
Seizures, 375 tympanopasty, 127, 135, 146
Sensorineural hearing loss. See also SSHL tympanotomy, 150
(sudden idiopathic sensorineural vestibuar nerve section through intracrania
hearing loss) main entry retrosigmoid approach (Ménière
Sickle cell disease, 221 vertigo), 199–200
Sleep disturbance, 353 Surgery altering CANS function
Smoking, 286 commissurotomy
Social impairment, 353 behavioral tests, 329–330
Spina bifida, 378 dichotic listening tests, 329
Spondyloepiphyseal dysplasia, 376 electrophysiologic tests, 330
SSCD (superior semicircular canal monaural low redundancy speech tests,
applicable copyright law.

dehiscence), 213–220 329–330

SSHL (sudden idiopathic sensorineural temporal processing tests, 329
hearing loss), 221–227 temporal lobectomy
SSI-ICM (synthetic sentence identification behavioral tests, 328
with ipsilateral competing message), dichotic listening tests, 328
289, 300, 302 electrophysiologic tests, 328–329
SSW (staggered spondaic word) test, 302, 325 temporal processing tests, 328

EBSCO Publishing : eBook Academic Collection (EBSCOhost) - printed on 2/3/2018 6:22 AM via AUB UNIV LIBRARIES
AN: 746799 ; Musiek, Frank E..; Disorders of the Auditory System
Account: s6501866
 415
Index
Copyright © 2012. Plural Publishing, Inc. All rights reserved. May not be reproduced in any form without permission from the publisher, except fair uses permitted under U.S. or

Syncopal episodes, 375 Tinnitus, 138, 189, 194, 199, 204, 218, 240
Syndactyly, 377 etiology, 347
Sypillis, 350 medical/audiologic evaluation, 349–352
medical/audiologic treatment
neurophysiologic rehabilitation, 355–357
T overview, 352
Tachycardia, 134 pharmacologic, 354
TBI (traumatic brain injury) and CANS, psychological, 352–354
316–323 sound generators/maskers, 354–355
T-cell lymphocytes, 205 overview, 345–347
Temporal bone trauma, 221 pathology, 347–348
audiologic examination, 145–146, 171–172 prevalence, 347
audiologic management, 146 pulsatile, 132, 136
audiologic management, 172–173 site of lesion, 348–349
case study: ossicular disarticulation symptom characteristics, 347
audiologic examination result, 148 Tinnitus Coping Style Questionnaire, 353
audiologic recommencation/ Tinnitus Handicap Inventory, 353
managements, 148 Tinnitus Handicap Questionnaire, 353
comments, 148, 150 Tinnitus Reaction Questionnaire, 353
history, 148 TMS (transcranial magnetic stimulation), 364
impression, 148 Tobramycin, 188
medical examination result, 148 Tongue paralysis, 132
case study: ossicular dislocation/ Toxoplasmosis, 221
conductive hearng loss Treacher Collins syndrome, 107, 376, 379
additional information, 152 Trisomy 21, 379–380
audiologic examination result, 150–152 TRT (Tinnitus Retraining Therapy), 356, 360
audiologic recommendation/ Tubecuolsis, 115
management, 150 TWV (traveling wave velocity) test, 197
history, 150 Tympanic membrane perforation, 153
impression, 150 Tympanosclerosis, 153–154
medical examination result, 150
case study: auditory processing/vestibular
deficits
U
audiologic examination results, 174–177 Upper respiratory infection, 115
audiologic recommendations/ Usher syndrome, 375, 377, 385
management, 178
impression, 178
medical examination results, 178
V
Temporal bone trauma  (continued) Valsalva, Antonio M. (1666–1723), 138
etiology, 144–145 Vancomycin, 188
etiology/pathology, 170–171 Vascular disorders of CANS
medical examination, 146 audiologic examination
medical examination, 146, 172 auditory brainstem response, 290
medical management, 146–148 behavioral test procedures, 287–290
applicable copyright law.

overview, 144, 170 binaural interaction tests, 289–290

pathology, 145 dichotic listening tests, 287–288
prevalence, 170 electrophysiologic tests, 290–292
site of lesion, 145, 171 late responses (N1, P2), 291
symptoms, 144, 170 middle latency response, 290–291
Temporal lobe epilepsy and CANS, 323–328 monaural low redundancy speech tests,
THT (Tinnitus Habituation Therapy), 356 289

EBSCO Publishing : eBook Academic Collection (EBSCOhost) - printed on 2/3/2018 6:22 AM via AUB UNIV LIBRARIES
AN: 746799 ; Musiek, Frank E..; Disorders of the Auditory System
Account: s6501866
 416 Disorders of the Auditory System
Copyright © 2012. Plural Publishing, Inc. All rights reserved. May not be reproduced in any form without permission from the publisher, except fair uses permitted under U.S. or

Vascular disorders of CANS  (continued) BPPV (benign paroxysmal vertigo) tests,

P300 response, 291–292 84–85
temporal processing tests, 288–289 caloric testing, 85–86
case study differential diagnoses variables/
temporal lobe tumor, 292–294 domains, 82–83
audiologic examination results, 292–293 ocuomotor tests, 83–84
history, 292 VEMPs (vestibular evoked myogenic
medical examination results, 292, 294 potentials), 86–87
temporoparietal stroke, VNG (videostagmography)/ENG
audiologic examination, 294, 296 (electronystagmography)
audiologic management, 296 BPPV (benign paroxysmal vertigo) tests,
history, 292 84–85
impression, 294 caloric testing, 85–86
medical examination/management, 294 differential diagnoses variables/
etiology, 285–286 domains, 82–83
medical management, 286–287 oculomotor tests, 83–84
overview, 284–285 positional/positioning tests, 84–85
prevalence, 285 Vestibular dysfunction, 377–378
site of lesion, 286 Vestibular problems, 380
Vascular loops, 267–274, 347 Vestibular suppressants, 199
Vascular spasm, 221 Vestibular system overview, 11–12
VATER (vertebral defects, anal atresia, Vocal fold paralysis, unilateral, 132
tracheoesophageal fistula, radial/ von Békésy, Georg (1899–1972)
renal anomalies) complex, 107 place theory, 29
Venous hum, 347 von Recklinghausen disease, 382
Versenate, 309
Vertebrobasilar disease, 221
Vertigo, 132, 148, 173, 194, 199, 216, 218. See
W
also Disequilibrium Waardenburg syndrome, 376–378, 385
Vestibular assessment. See also Audiologic Warfarin, 287
assessment Weber test, 172
ENG (electronystagmography)/VNG Wegener’s graulomatosis, 115, 205–206
(videostagmography), 82–86
applicable copyright law.

EBSCO Publishing : eBook Academic Collection (EBSCOhost) - printed on 2/3/2018 6:22 AM via AUB UNIV LIBRARIES
AN: 746799 ; Musiek, Frank E..; Disorders of the Auditory System
Account: s6501866